Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making
International Journal of Cancer · 01.09.2026 · 159 (5) · 1096-1108
DOI: 10.1002/ijc.70307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 29.12.2025. Verfasst von Martin Duval und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Service d'Oncologie Médicale, Hôpital Saint Antoine AP-HP, INSERM UMRS 938, Centre de Recherche Saint-Antoine, Equipe Instabilit…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Hereditary Nonpolyposis, Microsatellite Instability, DNA Mismatch Repair, Clinical Decision-Making. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 113 Literaturangaben.
Abstract (Originalsprache)
Deficiency in DNA mismatch repair (dMMR) is a common pathway of carcinogenesis across different tumor types and confers a characteristic microsatellite instability‐high (MSI‐H) molecular phenotype. The MSI‐H/dMMR phenotype may arise from an inherited pathogenic variant in the context of Lynch syndrome and is most frequently observed in endometrial, colorectal, and gastric cancers. MSI‐H/dMMR is a major predictive biomarker for the efficacy of immune‐checkpoint inhibitors (ICIs). Following the approval of ICIs for metastatic disease, these drugs are now being evaluated in localized disease settings. In this review, we provide an overview of current knowledge regarding the use of ICIs as neoadjuvant therapy and as a part of immuno‐ablative, surgery‐sparing strategies, with a focus on Lynch‐related cancers. Finally, we address the diagnosis, monitoring, and prevention challenges raised by these de‐escalation strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, Service d'Oncologie Médicale, Hôpital Saint Antoine AP-HP, INSERM UMRS 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe Labellisée par la Ligue Nation…
- Gut, Liver & Microbiome Research (GLIMMER) FHU, Paris, France.
- Service de Chirurgie Digestive, Hôpital Saint-Antoine AP-HP, Sorbonne Université, Paris, France.
- Service d'Endoscopie Digestive, Hôpital Saint-Antoine AP-HP, Sorbonne Université, Paris, France.
- Sorbonne Université, Service d'Imagerie, Hôpital Saint-Antoine, AP-HP, Laboratoire d'Imagerie Biomédicale, UMR 7371, UMR S 1146, Paris, France.
ORCID-Profile: Martin Duval, Leo Mas, Romain Cohen, Thierry André
Zitieren
APA
Duval, M., Dardenne, A., Samaille, T., Mas, L., Lefèvre, J. H., Dray, X., Wagner, M., Cohen, R., & André, T. (2026). Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making. International Journal of Cancer, 159(5), 1096-1108. https://doi.org/10.1002/ijc.70307
Vancouver
Duval M, Dardenne A, Samaille T, Mas L, Lefèvre JH, Dray X, et al. Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making. International Journal of Cancer. 2026;159(5):1096-1108. doi:10.1002/ijc.70307
BibTeX
@article{Duval2026,
author = {Duval, Martin and Dardenne, Antoine and Samaille, Thomas and Mas, Leo and Lefèvre, Jérémie H and Dray, Xavier and Wagner, Mathilde and Cohen, Romain and André, Thierry},
title = {Organ‐sparing strategies in patients with MSI / dMMR tumors including Lynch syndrome: Current state of the art and future perspectives for clinical decision‐making},
journal = {International Journal of Cancer},
year = {2026},
volume = {159},
number = {5},
pages = {1096--1108},
doi = {10.1002/ijc.70307}
}
EUVIMED